Farms.com Home   News

Farmers Disappointed With Lack of Clarity Around 45Z

The Department of Treasury released more details today about a tax credit, known as 45Z, that is designed to help the biofuel industry make inroads into the aviation sector. 

While today’s news included more information, corn grower leaders said they still need better clarity about the specific environmental practices that will be required for accessing the credit. 

“This is disappointing news for growers,” said Iowa Corn Growers Association President Stu Swanson. “We have continually advocated for clear guidelines from Treasury officials, working to provide them with the necessary information they need to get this done. Unfortunately, it feels like our input has gone unrecognized and this issue will now be passed to the new administration.”   

The 45Z tax credit was part of the Inflation Reduction Act, which was signed into law in 2022. The law provides tax incentives to refineries that produce biofuels that can be used in commercial aircraft to lower greenhouse gas emissions.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.